Anette Bygum
Overview
Explore the profile of Anette Bygum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
293
Citations
2248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drivenes J, Bygum A
Tidsskr Nor Laegeforen
. 2025 Feb;
145(2).
PMID: 39932088
No abstract available.
2.
Gram S, Brusgaard K, Lei U, Sommerlund M, Vinding G, Sleire S, et al.
JAMA Dermatol
. 2024 Dec;
161(2):157-166.
PMID: 39630431
Importance: Palmoplantar keratoderma poses diagnostic challenges due to its clinical and genetic heterogeneity, and knowledge on the value of systematic genetic testing on clinically well-described patient cohorts is sparse. Objective:...
3.
Drivenes J, Bygum A
Acta Derm Venereol
. 2024 Oct;
104:adv42012.
PMID: 39474676
No abstract available.
4.
Sofiudottir B, Munk H, Christensen R, Moller S, Overgaard S, Sorensen G, et al.
Rheumatol Int
. 2024 Oct;
44(12):2935-2947.
PMID: 39465398
Background: Currently, there are no reliable biomarkers for predicting treatment response in chronic inflammatory diseases (CIDs). Objective: To determine whether serum microfibrillar-associated protein 4 (MFAP4) levels can predict the treatment...
5.
Gregersen L, Jessen P, Lund H, Overgaard S, Hikmat Z, Ellingsen T, et al.
Scand J Immunol
. 2024 Oct;
100(6):e13409.
PMID: 39358910
Chronic inflammatory diseases (CIDs) pose a growing healthcare challenge, with a substantial proportion of patients showing inadequate response to biological treatment. There is renewed interest in dietary changes to optimize...
6.
7.
Drivenes J, Bygum A
Acta Derm Venereol
. 2024 Aug;
104:adv41006.
PMID: 39101343
No abstract available.
8.
Larsen M, Overgaard S, Petersen S, Mollegaard K, Munk H, Nexoe A, et al.
Scand J Immunol
. 2024 Jul;
100(3):e13395.
PMID: 38973149
The prevalence and disease burden of chronic inflammatory diseases (CIDs) are predicted to rise. Patients are commonly treated with biological agents, but the individual treatment responses vary, warranting further research...
9.
10.
Reshef A, Buttgereit T, Betschel S, Caballero T, Farkas H, Grumach A, et al.
J Allergy Clin Immunol
. 2024 Apr;
154(2):398-411.e1.
PMID: 38670233
Background: Angioedema (AE) manifests with intermittent, localized, self-limiting swelling of the subcutaneous and/or submucosal tissue. AE is heterogeneous, can be hereditary or acquired, may occur only once or be recurrent,...